Category: wiley

Cholesterol paper duplicated; “The authors believed that they had taken the necessary steps to withdraw.”

Biological Reviews

A review journal is pulling a 2013 article about advances in researchers’ understanding of cholesterol after seeing the same article in another journal.

Although the retracted paper appeared first — online in Biological Reviews in February, 2013 — the journal decided to retract it after learning the authors had initially submitted it elsewhere. The first submission was eventually published (with the exception of one author) in 2014 in Frontiers in Bioscience. 

The authors say they “believed that they had taken the necessary steps to withdraw their paper from Frontiers in Bioscience before they submitted to Biological Reviews in June 2012.” Here’s more from the retraction notice:

Continue reading Cholesterol paper duplicated; “The authors believed that they had taken the necessary steps to withdraw.”

“Dual submission issues” retract both copies of ovarian cancer paper

Journal of Cellular PhysiologyAuthors of a study on a potential biomarker for ovarian cancer have been hit with two retractions after the results were published twice.

We don’t usually see both copies of a duplicated paper retracted, but this is a somewhat unusual case. In November 2011, a group of authors submitted the paper to Gynecologic Oncology. But two months’ prior, the first author had decided to also submit the paper to the Journal of Cellular Physiology, without listing three of the other researchers, including the primary author on the paper. It was published by the Journal of Cellular Physiology first, then by Gynecologic Oncology, both in July, 2012. 

Jie Chen, first author on both articles, “takes full responsibility for the dual submission” and “other co-authors should be exempted from all responsibilities,” as the retraction notice from Gynecologic Oncology explains. 

Continue reading “Dual submission issues” retract both copies of ovarian cancer paper

P53 researcher submitted paper “without permission from his co-authors”

Screen Shot 2015-10-20 at 1.23.37 PM

One issue that we see pretty regularly is a paper submitted by one author without the permission of the others.

That’s what’s happened with “p53-induced Rap2B positively regulates migration in cells exposed to glucose deprivation,” published in July by Molecular Carcinogenesis. The paper looks at a protein called p53, well-known to regulate cell growth and, when mutated, cause cancer.

Here’s the pretty straightforward retraction note:

Continue reading P53 researcher submitted paper “without permission from his co-authors”

Correction restores confidence in results of confidence study

Strategic Management JournalA study that looked at how entrepreneurs’ confidence levels change depending on market conditions has been corrected to fix an error that flipped the results of one of the experiments.

The paper was published in 2013 by the Strategic Management Journal, and explored how entrepreneurs stay confident in difficult marketplaces by studying how people reacted to tasks of varying difficulty. In one experiment, participants were asked how well they thought they did on an easy quiz and how well they did on a hard quiz. Results showed that “participants underestimated their scores on the easy quiz” and “overestimated their performance on the difficult quiz.” However, authors wrote the opposite in the final paper.

Here’s the correction notice for “Making Sense of Overconfidence in Market Entry”:

Continue reading Correction restores confidence in results of confidence study

Cochrane withdraws criticized alcohol misuse report for “major errors”

Cochrane_LogoThe Cochrane Library has withdrawn a criticized 2014 meta-analysis about a technique to help young people avoid alcohol abuse, because of “major errors.” 

The review found that motivational interviewing, a form of counseling to help people change behaviors, showed some effects but had “no substantive, meaningful benefits” in preventing alcohol abuse among people 25 and younger. However, other researchers in the field, including some whose studies were included in the analysis, soon raised concerns about the review’s methods and data calculation, and the authors withdrew it. 

Here’s the brief notice for “Motivational interviewing for alcohol misuse in young adults:”

Continue reading Cochrane withdraws criticized alcohol misuse report for “major errors”

Authors retract second study about medical uses of honey

Journal of Clinical NursingA paper that tested the clinical value of honey on venous ulcers has been pulled by the Journal of Clinical Nursing after an investigation uncovered “errors in the data analysis.” Last year, the authors pulled another paper on the healing properties of honey on wounds. 

We just discovered this second retraction, which appears in the September 2015 issue of the journal, but was posted online last year.

The journal’s editor-in-chief, Debra Jackson, confirmed the dates and said that “a commercial company” brought the matter to their attention. After the journal asked a statistician to weigh in, they stated that a “substantial re-write would be required to correct the article,” and a retraction would be “the most suitable course of action.”

Although she said the authors initially sought to correct, not retract, the study, they eventually agreed with the decision.

Here’s the notice:

Continue reading Authors retract second study about medical uses of honey

“Insufficient permission” from funder resects liver disease paper

HepatologyA study on chronic liver inflammation was pulled from the journal Hepatology because of “insufficient permission by the authors’ funding institution to submit and publish the manuscript.” 

The paper, which was published in July, looked into how steatosis, the abnormal retention of fat in the liver, turns into steatohepatitis, also known as fatty liver disease. Researchers found that Treg cells play a central role in controlling the disease.

Unfortunately, the journal’s managing editor didn’t provide any information about the nature of the permission problems, and the notice doesn’t give any details.

Here it is, in full:

Continue reading “Insufficient permission” from funder resects liver disease paper

Image issues force retraction of liver transplant papers

ajtranspA group of researchers in Hong Kong and China have lost a pair of papers on liver transplantation after concerns were raised about the “origin of images” in the two studies.

The articles appeared in the American Journal of Transplantation in January and February of 2006, and came from the lab of S. T. Fan, of the University of Hong Kong. When the authors were asked about the images, they “were unable to satisfactorily mitigate the concerns.”

According to this bio from the journal Hepatobiliary Surgery and Nutrition, Fan: Continue reading Image issues force retraction of liver transplant papers

Urologist makes what he calls “clarifications” to multiple articles

Screen Shot 2015-09-30 at 10.22.32 AMWe have discovered several errata for a New York City urologist, including in one paper that previously inspired one of our favorite headlines.

The latest development is pretty straightforward: Ashutosh K. Tewari has issued errata to multiple papers in two journals that note changes to some data points. But the backstory has some twists and turns, so you may need to read this one carefully.

We’ll start with the paper that might be familiar to eagle-eyed readers, on incontinence after surgery: “Effect of a Risk- Grade of Nerve-sparing Technique on Early Return of Continence After Robot-assisted Laparoscopic Radical Prostatectomy.” It was published in European Urology in 2012, and has been cited 21 times, according Thomson Scientific’s Web of Knowledge. Here’s the correction note (paywalled  — tsk, tsk):

Continue reading Urologist makes what he calls “clarifications” to multiple articles

Cochrane withdraws review on zinc for colds for data concerns

Cochrane_LogoThe Cochrane Library has withdrawn a 2013 systematic review on zinc’s ability to fight the common cold.

Cochrane often marks reviews “withdrawn” once new evidence emerges that renders them out of date — but in this case, the review was flagged while the editors investigate issues “regarding the calculation and analysis of data.”

Here’s the notice.

Continue reading Cochrane withdraws review on zinc for colds for data concerns